Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy
Summary
Eli Lilly has established itself as the market leader in obesity drugs in Europe, Asia and the Middle East and expects t...
Eli Lilly has established itself as the market leader in obesity drugs in Europe, Asia and the Middle East and expects to replicate its U.S. dominance globally, the company's international president told Reuters on Wednesday.
Related Articles